WRN inhibitor 12, identified by its CAS number 3044040-29-8, is a small molecule designed to inhibit the activity of the Werner syndrome protein (WRN), which is involved in DNA repair and maintenance. This compound is of particular interest in cancer research and aging studies, as WRN plays a crucial role in genomic stability. The characteristics of WRN inhibitor 12 include its potential to selectively bind to the WRN helicase domain, thereby disrupting its function and leading to increased sensitivity of cancer cells to DNA-damaging agents. The compound is typically characterized by its molecular structure, which includes specific functional groups that facilitate its interaction with the target protein. Additionally, WRN inhibitor 12 may exhibit properties such as solubility in organic solvents, moderate stability under physiological conditions, and a defined pharmacokinetic profile that influences its bioavailability and efficacy in biological systems. Further studies are often conducted to evaluate its potency, selectivity, and potential side effects in various cellular models.

WRN inhibitor 12

3044040-29-8: WRN inhibitor 12, identified by its CAS number 3044040-29-8, is a small molecule designed to inhibit the activity of the Werner syndrome protein (WRN), which is involved in DNA repair and maintenance. This compound is of particular interest in cancer research and aging studies, as WRN plays a crucial role in genomic stability. The characteristics of WRN inhibitor 12 include its potential to selectively bind to the WRN helicase domain, thereby disrupting its function and leading to increased sensitivity of cancer cells to DNA-damaging agents. The compound is typically characterized by its molecular structure, which includes specific functional groups that facilitate its interaction with the target protein. Additionally, WRN inhibitor 12 may exhibit properties such as solubility in organic solvents, moderate stability under physiological conditions, and a defined pharmacokinetic profile that influences its bioavailability and efficacy in biological systems. Further studies are often conducted to evaluate its potency, selectivity, and potential side effects in various cellular models.

WRN inhibitor 12 (compound 5) serves as an inhibitor for the WRN helicase.

CAS 3044040-29-8

WRN inhibitor 12

WRN inhibitor 12

Ref: TM-T201316